miR-504 knockout regulates tumor cell proliferation and immune cell infiltration to accelerate oral cancer development

X Wang, X Song, Y Ma, J Yang, J Gao, T Wang… - Journal of Genetics and …, 2024 - Elsevier
Abstract miR-504 plays a pivotal role in the progression of oral cancer. However, the
underlying mechanism remains elusive in vivo. Here, we find that miR-504 is significantly …

Synergistic effect of the combination of Chrysanthemum cinerariifolium (Trev.) and doxorubicin in inhibiting PI3K and Cyclin D in oral squamous cell carcinoma …

A Listiyana, YL Rachmawati, H Susianti… - …, 2023 - f1000research.com
Background: The most common type of lips and oral cavity cancer is oral squamous cell
carcinoma (OSCC). Doxorubicin (DX) is commonly used as a chemotherapy drug, but its use …